Trial · NCT00869206
Adverse events914
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 914
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Blood disorder | Blood and lymphatic system disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 2 | 879 | 2 |
| other | Blood disorder | Blood and lymphatic system disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 2 | 868 | 2 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 10 | 879 | 14 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 7 | 868 | 8 |
| other | Hemoglobin decreased | Blood and lymphatic system disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 98 | 879 | 195 |
| other | Hemoglobin decreased | Blood and lymphatic system disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 92 | 868 | 206 |
| other | Hemolysis | Blood and lymphatic system disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 16 | 879 | 37 |
| other | Hemolysis | Blood and lymphatic system disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 11 | 868 | 29 |
| other | Lymphatic disorder | Blood and lymphatic system disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 3 | 879 | 5 |
| other | Lymphatic disorder | Blood and lymphatic system disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 1 | 868 | 1 |
| other | Thrombotic microangiopathy | Blood and lymphatic system disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 4 | 879 | 5 |
| other | Thrombotic microangiopathy | Blood and lymphatic system disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 1 | 868 | 2 |
| other | Atrial fibrillation | Cardiac disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 9 | 879 | 9 |
| other | Atrial fibrillation | Cardiac disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 2 | 868 | 2 |
| other | Atrial flutter | Cardiac disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 1 | 879 | 1 |
| other | Atrial flutter | Cardiac disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 0 | 868 | 0 |
| other | Atrial tachycardia | Cardiac disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 0 | 879 | 0 |
| other | Atrial tachycardia | Cardiac disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 1 | 868 | 1 |
| other | Cardiac disorder | Cardiac disorders | Arm I (Zoledronic Acid Every 4 Weeks) | 3 | 879 | 3 |
| other | Cardiac disorder | Cardiac disorders | Arm II (Zoledronic Acid Every 12 Weeks) | 4 | 868 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00869206/events